{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:04:39Z","timestamp":1790283879626,"version":"4.1.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.lfs.2024.123164","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T16:31:20Z","timestamp":1729701080000},"page":"123164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Association between hepatocyte TM4SF5 expression and gut microbiome dysbiosis during non-alcoholic fatty liver disease development"],"prefix":"10.1016","volume":"358","author":[{"given":"Yangie Dwi","family":"Pinanga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-hee","family":"Pyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Ae","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haesong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Hae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonsik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Eon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Weon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lfs.2024.123164_bb0005","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jhep.2023.03.040","article-title":"Global incidence of non-alcoholic fatty liver disease: a systematic review and meta-analysis of 63 studies and 1,201,807 persons","volume":"79","author":"Le","year":"2023","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.lfs.2024.123164_bb0010","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbcan.2018.11.005","article-title":"Advancing the understanding of NAFLD to hepatocellular carcinoma development: from experimental models to humans","volume":"1871","author":"Chen","year":"2019","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"suppl","key":"10.1016\/j.lfs.2024.123164_bb0015","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.3350\/cmh.2022.0424","article-title":"Non-alcoholic fatty liver disease: definition and subtypes","volume":"29","author":"Han","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.lfs.2024.123164_bb0020","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2862173","article-title":"The pathogenesis of nonalcoholic fatty liver disease: interplay between diet, gut microbiota, and genetic background","volume":"2016","author":"Yu","year":"2016","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.lfs.2024.123164_bb0025","article-title":"Microbiome therapeutics: exploring the present scenario and challenges","volume":"10","author":"Yadav","year":"2022","journal-title":"Gastroenterol. Rep. (Oxf.)"},{"issue":"5","key":"10.1016\/j.lfs.2024.123164_bb0030","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","article-title":"Gut microbiome and health: mechanistic insights","volume":"71","author":"de Vos","year":"2022","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.lfs.2024.123164_bb0035","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.jhep.2021.12.003","article-title":"Promises of microbiome-based therapies","volume":"76","author":"Bajaj","year":"2022","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.lfs.2024.123164_bb0040","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cmet.2017.04.001","article-title":"Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease","volume":"25","author":"Loomba","year":"2017","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.lfs.2024.123164_bb0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/cld.1010","article-title":"The influence of the microbiome on NAFLD and NASH","volume":"17","author":"Albhaisi","year":"2021","journal-title":"Clin. Liver Dis. (Hoboken)"},{"issue":"12","key":"10.1016\/j.lfs.2024.123164_bb0050","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/s42255-021-00501-9","article-title":"Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity","volume":"3","author":"Tilg","year":"2021","journal-title":"Nat. Metab."},{"issue":"28","key":"10.1016\/j.lfs.2024.123164_bb0055","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.4254\/wjh.v7.i28.2811","article-title":"Bile acid receptors and nonalcoholic fatty liver disease","volume":"7","author":"Yuan","year":"2015","journal-title":"World J. Hepatol."},{"issue":"6","key":"10.1016\/j.lfs.2024.123164_bb0060","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3390\/biomedicines8060154","article-title":"Free fatty acid receptors 2 and 3 as microbial metabolite sensors to shape host health: pharmacophysiological view","volume":"8","author":"Mishra","year":"2020","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.lfs.2024.123164_bb0065","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41467-020-20422-7","article-title":"Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma","volume":"12","author":"Behary","year":"2021","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.lfs.2024.123164_bb0070","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1111\/jgh.15027","article-title":"Endogenous ethanol produced by intestinal bacteria induces mitochondrial dysfunction in non-alcoholic fatty liver disease","volume":"35","author":"Chen","year":"2020","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"15","key":"10.1016\/j.lfs.2024.123164_bb0075","doi-asserted-by":"crossref","first-page":"8387","DOI":"10.3390\/ijms23158387","article-title":"TM4SF5-mediated regulation of hepatocyte transporters during metabolic liver diseases","volume":"23","author":"Kim","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.lfs.2024.123164_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110018","article-title":"TM4SF5-dependent crosstalk between hepatocytes and macrophages to reprogram the inflammatory environment","volume":"37","author":"Kim","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.lfs.2024.123164_bb0085","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/bs.ircmb.2015.06.004","article-title":"Transmembrane 4 L six family member 5 (TM4SF5)-mediated epithelial-mesenchymal transition in liver diseases","volume":"319","author":"Lee","year":"2015","journal-title":"Int. Rev. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.lfs.2024.123164_bb0090","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s12276-019-0363-7","article-title":"Amino acid transporters as tetraspanin TM4SF5 binding partners","volume":"52","author":"Jung","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.lfs.2024.123164_bb0095","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.2741\/3818","article-title":"Modulation of signaling between TM4SF5 and integrins in tumor microenvironment","volume":"16","author":"Lee","year":"2011","journal-title":"Front. Biosci."},{"issue":"4","key":"10.1016\/j.lfs.2024.123164_bb0100","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1096\/fj.201600944RR","article-title":"Dynamic and coordinated single-molecular interactions at TM4SF5-enriched microdomains guide invasive behaviors in 2- and 3-dimensional environments","volume":"31","author":"Kim","year":"2017","journal-title":"FASEB J."},{"issue":"9","key":"10.1016\/j.lfs.2024.123164_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107625","article-title":"TM4SF5-mediated abnormal food-intake behavior and apelin expression facilitate non-alcoholic fatty liver disease features","volume":"26","author":"Pinanga","year":"2023","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.lfs.2024.123164_bb0110","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/path.5548","article-title":"Differential TM4SF5-mediated SIRT1 modulation and metabolic signaling in nonalcoholic steatohepatitis progression","volume":"253","author":"Ryu","year":"2021","journal-title":"J. Pathol."},{"key":"10.1016\/j.lfs.2024.123164_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101451","article-title":"Crosstalk between TM4SF5 and GLUT8 regulates fructose metabolism in hepatic steatosis","volume":"58","author":"Lee","year":"2022","journal-title":"Mol. Metab."},{"issue":"9","key":"10.1016\/j.lfs.2024.123164_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12262","article-title":"Liver-originated small extracellular vesicles with TM4SF5 target brown adipose tissue for homeostatic glucose clearance","volume":"11","author":"Jung","year":"2022","journal-title":"J. Extracell. Vesicles"},{"issue":"11","key":"10.1016\/j.lfs.2024.123164_bb0125","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1101\/gr.094680.109","article-title":"Rapid inexpensive genome-wide association using pooled whole blood","volume":"19","author":"Craig","year":"2009","journal-title":"Genome Res."},{"key":"10.1016\/j.lfs.2024.123164_bb0130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.annepidem.2019.09.002","article-title":"High-throughput sequencing of pooled samples to determine community-level microbiome diversity","volume":"39","author":"Ray","year":"2019","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.lfs.2024.123164_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mimet.2014.08.022","article-title":"To pool or not to pool? Impact of the use of individual and pooled fecal samples for in vitro fermentation studies","volume":"107","author":"Aguirre","year":"2014","journal-title":"J. Microbiol. Methods"},{"key":"10.1016\/j.lfs.2024.123164_bb0140","article-title":"Pooled faecal inoculum can predict infant fiber fermentability despite high inter-individual variability of microbiota composition","volume":"24","author":"Logtenberg","year":"2020","journal-title":"Bioact. Carbohydr. Diet. Fibre"},{"issue":"1","key":"10.1016\/j.lfs.2024.123164_bb0145","first-page":"11","article-title":"Optimal alignments in linear space","volume":"4","author":"Myers","year":"1988","journal-title":"Comput. Appl. Biosci."},{"key":"10.1016\/j.lfs.2024.123164_bb0150","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.2584","article-title":"VSEARCH: a versatile open source tool for metagenomics","volume":"4","author":"Rognes","year":"2016","journal-title":"PeerJ"},{"issue":"5","key":"10.1016\/j.lfs.2024.123164_bb0155","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1099\/ijsem.0.001755","article-title":"Introducing EzBioCloud: a taxonomically united database of 16S rRNA gene sequences and whole-genome assemblies","volume":"67","author":"Yoon","year":"2017","journal-title":"Int. J. Syst. Evol. Microbiol."},{"issue":"16","key":"10.1016\/j.lfs.2024.123164_bb0160","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1093\/bioinformatics\/btr381","article-title":"UCHIME improves sensitivity and speed of chimera detection","volume":"27","author":"Edgar","year":"2011","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.lfs.2024.123164_bb0165","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s13059-019-1891-0","article-title":"Improved metagenomic analysis with Kraken 2","volume":"20","author":"Wood","year":"2019","journal-title":"Genome Biol."},{"issue":"3","key":"10.1016\/j.lfs.2024.123164_bb0170","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/bioinformatics\/bty648","article-title":"Scaling read aligners to hundreds of threads on general-purpose processors","volume":"35","author":"Langmead","year":"2019","journal-title":"Bioinformatics"},{"issue":"6","key":"10.1016\/j.lfs.2024.123164_bb0175","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","article-title":"BEDTools: a flexible suite of utilities for comparing genomic features","volume":"26","author":"Quinlan","year":"2010","journal-title":"Bioinformatics"},{"issue":"6","key":"10.1016\/j.lfs.2024.123164_bb0180","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","article-title":"Metagenomic biomarker discovery and explanation","volume":"12","author":"Segata","year":"2011","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.lfs.2024.123164_bb0185","article-title":"17beta-Estradiol supplementation changes gut microbiota diversity in intact and colorectal cancer-induced ICR male mice","volume":"10","author":"Song","year":"2020","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.lfs.2024.123164_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000465","article-title":"A parsimony approach to biological pathway reconstruction\/inference for genomes and metagenomes","volume":"5","author":"Ye","year":"2009","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.lfs.2024.123164_bb0195","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.3389\/fphys.2018.01813","article-title":"Intestinal microbiota modulation in obesity-related non-alcoholic fatty liver disease","volume":"9","author":"Porras","year":"2018","journal-title":"Front. Physiol."},{"issue":"3","key":"10.1016\/j.lfs.2024.123164_bb0200","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.aohep.2018.10.003","article-title":"A different gut microbiome linked to inflammation found in cirrhotic patients with and without hepatocellular carcinoma","volume":"18","author":"Pinero","year":"2019","journal-title":"Ann. Hepatol."},{"issue":"1","key":"10.1016\/j.lfs.2024.123164_bb0205","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/s41467-019-09455-9","article-title":"A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease","volume":"10","author":"Caussy","year":"2019","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.lfs.2024.123164_bb0210","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/gutjnl-2014-308778","article-title":"Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology","volume":"65","author":"Dao","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2024.123164_bb0215","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3389\/fmicb.2018.00757","article-title":"Role of Lactobacillus reuteri in human health and diseases","volume":"9","author":"Mu","year":"2018","journal-title":"Front. Microbiol."},{"issue":"6","key":"10.1016\/j.lfs.2024.123164_bb0220","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3390\/nu13062032","article-title":"Gut microbiota profile and its association with clinical variables and dietary intake in overweight\/obese and lean subjects: a cross-sectional study","volume":"13","author":"Companys","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.lfs.2024.123164_bb0225","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1038\/s41598-021-84928-w","article-title":"Gut microbiota markers associated with obesity and overweight in Italian adults","volume":"11","author":"Palmas","year":"2021","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.lfs.2024.123164_bb0230","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3390\/microorganisms8040573","article-title":"The controversial role of human gut Lachnospiraceae","volume":"8","author":"Vacca","year":"2020","journal-title":"Microorganisms"},{"issue":"7","key":"10.1016\/j.lfs.2024.123164_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134333","article-title":"Obesity alters the microbial community profile in Korean adolescents","volume":"10","author":"Hu","year":"2015","journal-title":"PLoS One"},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2024.123164_bb0240","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jfma.2018.07.009","article-title":"The gut microbiome in obesity","volume":"118","author":"Tseng","year":"2019","journal-title":"J. Formos. Med. Assoc."},{"issue":"10","key":"10.1016\/j.lfs.2024.123164_bb0245","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1039\/D0FO03331F","article-title":"Effects of three different mannans on obesity and gut microbiota in high-fat diet-fed C57BL\/6J mice","volume":"12","author":"Song","year":"2021","journal-title":"Food Funct."},{"issue":"1","key":"10.1016\/j.lfs.2024.123164_bb0250","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12263-021-00703-6","article-title":"Gut microbiota in patients with obesity and metabolic disorders - a systematic review","volume":"17","author":"Xu","year":"2022","journal-title":"Genes Nutr."},{"issue":"6","key":"10.1016\/j.lfs.2024.123164_bb0255","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3390\/metabo11060353","article-title":"Gut microbiome and metabolites in patients with NAFLD and after bariatric surgery: a comprehensive review","volume":"11","author":"Hoozemans","year":"2021","journal-title":"Metabolites"},{"issue":"2","key":"10.1016\/j.lfs.2024.123164_bb0260","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1053\/j.gastro.2020.03.010","article-title":"Lactococcus lactis subspecies cremoris elicits protection against metabolic changes induced by a Western-style diet","volume":"159","author":"Naudin","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2024.123164_bb0265","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3389\/fimmu.2017.01166","article-title":"Human gut symbiont Roseburia hominis promotes and regulates innate immunity","volume":"8","author":"Patterson","year":"2017","journal-title":"Front. Immunol."},{"issue":"18","key":"10.1016\/j.lfs.2024.123164_bb0270","article-title":"Roseburia hominis alleviates neuroinflammation via short-chain fatty acids through histone deacetylase inhibition","volume":"66","author":"Song","year":"2022","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.lfs.2024.123164_bb0275","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.3389\/fmicb.2019.02411","article-title":"A short-term feeding of dietary casein increases abundance of Lactococcus lactis and upregulates gene expression involving obesity prevention in cecum of young rats compared with dietary chicken protein","volume":"10","author":"Zhao","year":"2019","journal-title":"Front. Microbiol."},{"issue":"7","key":"10.1016\/j.lfs.2024.123164_bb0280","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.4254\/wjh.v14.i7.1277","article-title":"Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis","volume":"14","author":"Liakina","year":"2022","journal-title":"World J. Hepatol."},{"issue":"15","key":"10.1016\/j.lfs.2024.123164_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512232","article-title":"Adlercreutzia equolifaciens is an anti-inflammatory commensal bacterium with decreased abundance in gut microbiota of patients with metabolic liver disease","volume":"24","author":"Onate","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123164_bb0290","doi-asserted-by":"crossref","DOI":"10.1177\/17562848221098243","article-title":"Changes in the gut microbiome associated with liver stiffness improvement in nonalcoholic steatohepatitis","volume":"15","author":"Sharpton","year":"2022","journal-title":"Ther. Adv. Gastroenterol."},{"issue":"10","key":"10.1016\/j.lfs.2024.123164_bb0295","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.ajpath.2021.06.010","article-title":"Methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis is associated with increased intestinal inflammation","volume":"191","author":"Matthews","year":"2021","journal-title":"Am. J. Pathol."},{"issue":"11","key":"10.1016\/j.lfs.2024.123164_bb0300","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.drudis.2017.06.007","article-title":"Mouse models of nonalcoholic steatohepatitis in preclinical drug development","volume":"22","author":"Hansen","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.lfs.2024.123164_bb0305","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.603926","article-title":"Non-alcoholic steatohepatitis: a review of its mechanism, models and medical treatments","volume":"11","author":"Peng","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2024.123164_bb0310","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jhep.2020.04.011","article-title":"Animal models for liver disease - a practical approach for translational research","volume":"73","author":"Nevzorova","year":"2020","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.lfs.2024.123164_bb0315","doi-asserted-by":"crossref","DOI":"10.1038\/nmicrobiol.2016.131","article-title":"The Mouse Intestinal Bacterial Collection (miBC) provides host-specific insight into cultured diversity and functional potential of the gut microbiota","volume":"1","author":"Lagkouvardos","year":"2016","journal-title":"Nat. Microbiol."},{"issue":"15","key":"10.1016\/j.lfs.2024.123164_bb0320","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.3390\/ijms20153624","article-title":"Targeting long chain acyl-CoA synthetases for cancer therapy","volume":"20","author":"Rossi Sebastiano","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123164_bb0325","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.949563","article-title":"Genomic reconstruction of short-chain fatty acid production by the human gut microbiota","volume":"9","author":"Frolova","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"9","key":"10.1016\/j.lfs.2024.123164_bb0330","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1038\/s41396-021-00937-7","article-title":"Key bacterial taxa and metabolic pathways affecting gut short-chain fatty acid profiles in early life","volume":"15","author":"Tsukuda","year":"2021","journal-title":"ISME J."},{"issue":"4","key":"10.1016\/j.lfs.2024.123164_bb0335","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3390\/nu15040987","article-title":"Comparison of the activity of fecal enzymes and concentration of SCFA in healthy and overweight children","volume":"15","author":"Slizewska","year":"2023","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.lfs.2024.123164_bb0340","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.cmet.2020.06.005","article-title":"A universal gut-microbiome-derived signature predicts cirrhosis","volume":"32","author":"Oh","year":"2020","journal-title":"Cell Metab."},{"issue":"23","key":"10.1016\/j.lfs.2024.123164_bb0345","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.3748\/wjg.v24.i23.2468","article-title":"Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis","volume":"24","author":"Ye","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2024.123164_bb0350","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.3389\/fmicb.2018.01967","article-title":"Butyrate protects mice against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis by improving gut barrier function, attenuating Inflam- mation and reducing endotoxin levels","volume":"9","author":"Ye","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.lfs.2024.123164_bb0355","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.trsl.2020.07.008","article-title":"The GLP-1R agonist liraglutide limits hepatic lipotoxicity and inflammatory response in mice fed a methionine-choline deficient diet","volume":"227","author":"Somm","year":"2021","journal-title":"Transl. Res."},{"key":"10.1016\/j.lfs.2024.123164_bb0360","article-title":"Western diet-induced mouse model of non-alcoholic fatty liver disease associated with metabolic outcomes: features of gut microbiome-liver-adipose tissue axis","volume":"103\u2013104","author":"Romualdo","year":"2022","journal-title":"Nutrition"},{"issue":"7","key":"10.1016\/j.lfs.2024.123164_bb0365","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.03004-19","article-title":"Akkermansia muciniphila prevents fatty liver disease, decreases serum triglycerides, and maintains gut homeostasis","volume":"86","author":"Kim","year":"2020","journal-title":"Appl. Environ. Microbiol."},{"issue":"1","key":"10.1016\/j.lfs.2024.123164_bb0370","doi-asserted-by":"crossref","first-page":"6701","DOI":"10.1038\/s41598-023-33806-8","article-title":"Gut microbiota induces hepatic steatosis by modulating the T cells balance in high fructose diet mice","volume":"13","author":"Zhou","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.lfs.2024.123164_bb0375","doi-asserted-by":"crossref","first-page":"50","DOI":"10.12938\/bmfh.2020-046","article-title":"Correlation of gut Firmicutes\/Bacteroidetes ratio with fibrosis and steatosis stratified by body mass index in patients with non-alcoholic fatty liver disease","volume":"40","author":"Jasirwan","year":"2021","journal-title":"Biosci. Microbiota Food Health"},{"issue":"1","key":"10.1016\/j.lfs.2024.123164_bb0380","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3350\/cmh.2020.0125","article-title":"Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis","volume":"27","author":"Lee","year":"2021","journal-title":"Clin. Mol. Hepatol."},{"issue":"3","key":"10.1016\/j.lfs.2024.123164_bb0385","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3390\/biomedicines10030550","article-title":"Gut microbiome in non-alcoholic fatty liver disease: from mechanisms to therapeutic role","volume":"10","author":"Gupta","year":"2022","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.lfs.2024.123164_bb0390","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/s41430-020-0607-6","article-title":"Profile of the gut microbiota of adults with obesity: a systematic review","volume":"74","author":"Crovesy","year":"2020","journal-title":"Eur. J. Clin. Nutr."},{"issue":"5","key":"10.1016\/j.lfs.2024.123164_bb0395","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.3390\/nu12051474","article-title":"The Firmicutes\/Bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients?","volume":"12","author":"Magne","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.lfs.2024.123164_bb0400","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.700058","article-title":"Role of the gut microbiota in regulating non-alcoholic fatty liver disease in children and adolescents","volume":"8","author":"Tokuhara","year":"2021","journal-title":"Front. Nutr."},{"key":"10.1016\/j.lfs.2024.123164_bb0405","article-title":"Altered fecal microbiota correlates with liver biochemistry in nonobese patients with non-alcoholic fatty liver disease","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.lfs.2024.123164_bb0410","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/s41598-018-19753-9","article-title":"Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance","volume":"8","author":"Da Silva","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.lfs.2024.123164_bb0415","first-page":"170","article-title":"Probiotics for gastrointestinal conditions: a summary of the evidence","volume":"96","author":"Wilkins","year":"2017","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.lfs.2024.123164_bb0420","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.906511","article-title":"Effects of dietary nutrients on fatty liver disease associated with metabolic dysfunction (MAFLD): based on the intestinal-hepatic axis","volume":"9","author":"Yao","year":"2022","journal-title":"Front. Nutr."},{"issue":"Pt 5","key":"10.1016\/j.lfs.2024.123164_bb0425","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1099\/ijs.0.02873-0","article-title":"Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium","volume":"54","author":"Derrien","year":"2004","journal-title":"Int. J. Syst. Evol. Microbiol."},{"issue":"5","key":"10.1016\/j.lfs.2024.123164_bb0430","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S1665-2681(19)31246-3","article-title":"Probiotics and synbiotics may improve liver aminotransferases levels in non-alcoholic fatty liver disease patients","volume":"13","author":"Buss","year":"2014","journal-title":"Ann. Hepatol."},{"issue":"3","key":"10.1016\/j.lfs.2024.123164_bb0435","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2018.09.004","article-title":"Dysregulated microbial fermentation of soluble fiber induces cholestatic liver cancer","volume":"175","author":"Singh","year":"2018","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.lfs.2024.123164_bb0440","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.3390\/microorganisms9112402","article-title":"Gut microbiota parameters potentially useful in clinical perspective","volume":"9","author":"Di Pierro","year":"2021","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.lfs.2024.123164_bb0445","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/oby.2009.167","article-title":"Microbiota and SCFA in lean and overweight healthy subjects","volume":"18","author":"Schwiertz","year":"2010","journal-title":"Obesity (Silver Spring)"},{"issue":"2","key":"10.1016\/j.lfs.2024.123164_bb0450","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3945\/an.114.007450","article-title":"Microbial degradation of whole-grain complex carbohydrates and impact on short-chain fatty acids and health","volume":"6","author":"Bach Knudsen","year":"2015","journal-title":"Adv. Nutr."},{"issue":"7122","key":"10.1016\/j.lfs.2024.123164_bb0455","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/nature05414","article-title":"An obesity-associated gut microbiome with increased capacity for energy harvest","volume":"444","author":"Turnbaugh","year":"2006","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.lfs.2024.123164_bb0460","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1053\/j.gastro.2013.04.056","article-title":"Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice","volume":"145","author":"Kim","year":"2013","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.lfs.2024.123164_bb0465","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.cell.2016.05.018","article-title":"The colonic crypt protects stem cells from microbiota-derived metabolites","volume":"165","author":"Kaiko","year":"2016","journal-title":"Cell"},{"issue":"Suppl","key":"10.1016\/j.lfs.2024.123164_bb0470","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1097\/MCG.0b013e31822fecfe","article-title":"Fermentation in the human large intestine: its physiologic consequences and the potential contribution of prebiotics","volume":"45","author":"Macfarlane","year":"2011","journal-title":"J. Clin. Gastroenterol."},{"issue":"2","key":"10.1016\/j.lfs.2024.123164_bb0475","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1017\/S0954422410000247","article-title":"From the gut to the peripheral tissues: the multiple effects of butyrate","volume":"23","author":"Guilloteau","year":"2010","journal-title":"Nutr. Res. Rev."},{"issue":"5","key":"10.1016\/j.lfs.2024.123164_bb0480","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s12276-021-00614-x","article-title":"The interaction between the gut microbiota and dietary carbohydrates in nonalcoholic fatty liver disease","volume":"53","author":"Park","year":"2021","journal-title":"Exp. Mol. Med."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524007549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524007549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:40:06Z","timestamp":1736185206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320524007549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":96,"alternative-id":["S0024320524007549"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.123164","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between hepatocyte TM4SF5 expression and gut microbiome dysbiosis during non-alcoholic fatty liver disease development","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.123164","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123164"}}